“The effectiveness of new hormone therapy treatments on progression-free survival of patients with HR+/HER2- metastatic breast cancer: a systematic review” (2021) Research, Society and Development, 10(14), p. e85101421940. doi:10.33448/rsd-v10i14.21940.